Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pilot Study of Safety and Efficacy of Sodium Phenylbutyrate in Spinocerebellar Ataxia Type 3

This study has been withdrawn prior to enrollment.
(Regulatory authorities did not allow the entrance of the study drug in the country)
Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul, Brazil
Information provided by (Responsible Party):
Hospital de Clinicas de Porto Alegre Identifier:
First received: March 29, 2010
Last updated: August 15, 2012
Last verified: May 2010
No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: July 2011
  Estimated Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)